Background A variety of protocols exist for the treatment of Bowen's diseas
e by photodynamic therapy (PDT) using topical 5-aminolaevulinic acid (5-ALA
).
Objective To determine the optimal wavelength (red or green light) for this
treatment.
Methods A randomized comparison study of ALA-PDT using red (630 +/- 15 nm)
or green (540 +/- 15 nm) light in the treatment of Bowen's disease.
Results The initial clearance rate for lesions treated by red light was 94%
(30 of 32) in comparison with 72% (21 of 29) for those lesions receiving g
reen light (P = 0.002). Over the following 12 months, there were two recurr
ences in the red light group and seven in the green light group reducing th
e clearance rates to 88% and 48%, respectively. The frequency and severity
of pain experienced were similar between the two treatment groups. No hyper
thermia, nor significant difference in lesional temperatures, was observed
between the wavelengths studied.
Conclusion Green light is less effective than red light, at a theoretically
equivalent dose, in the treatment of Bowen's disease by topical ALA-PDT.